首页> 外文期刊>Bioorganic and medicinal chemistry >Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)
【24h】

Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4)

机译:CXC趋化因子受体4(CXCR4)基于支架的三脂瘤拮抗剂的设计,合成和生物学评估(CXCR4)

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Structure-activity relationship studies of the cyclopentapeptide CXCR4 antagonists (cyclo(-L-/D-Arg(1)-Arg(2)-2-Nal(3)-Gly(4)-D-Tyr(5)-)) suggest that the L-/D-Arg(1)-Arg(2)-2-Nal(3) tripeptide sequence contained within these cyclopentapeptides serves as a recognition motif for peptidic CXCR4 antagonists. Starting by dissecting the cyclopentapeptide structure and reintroducing cyclic constraints in a stepwise manner, we here report a novel class of scaffold-based tripeptidomimetic CXCR4 antagonists based on the D-Arg-Arg-2-Nal motif. Biological testing of the prototype compounds showed that they represent new peptidomimetic hits; importantly, the modular nature of the scaffold provides an interesting starting point for future ligand optimization. (C) 2014 Elsevier Ltd. All rights reserved.
机译:环戊肽CXCR4拮抗剂的结构 - 活性关系研究(Cyclo(-L- / D-Arg(1)-Arg(2)-2-NAL(3)-gly(4)-D-TYR(5) - ))) 建议在这些环戊肽中包含的L- / D-ARG(1)-ARG(2)-2-NAL(3)三肽序列用作肽CXCR4拮抗剂的识别基序。 通过逐步解剖环戊肽结构和重新引入循环约束,我们在此报告了一种基于D-Arg-Arg-2-NAL基序的新型基于支架的三脂瘤CXCR4拮抗剂。 原型化合物的生物学检测表明它们代表了新的肽模拟物击中; 重要的是,脚手架的模块化性质为未来配体优化提供了一个有趣的起点。 (c)2014年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号